Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date The Enhancement of Management of breast cancer in French speaking Sub-Saharan African CountriesRelease Date:Partner: AMFROMQuality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize ManagementRelease Date:Partner: Beijing Guangda Precision Medicine Research CenterQuality Improvement Inflammation & Immunology China Optimizing Antimicrobial Stewardship Program in Saudi ArabiaRelease Date:Quality Improvement Inflammation & Immunology Saudi Arabia Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with IsavuconazoleRelease Date:Research Inflammation & Immunology Australia, Germany, Israel, Italy, Spain, Switzerland PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate CancerRelease Date:Education Oncology USA Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026Release Date:Research Vaccines India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infectionRelease Date:Education Vaccines Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac eraRelease Date:Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRERelease Date:Research Hospital China, Hong Kong COVID-19 Disease Burden on the High Risk PopulationRelease Date:Education Vaccines All New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel DiseaseRelease Date:Research Inflammation & Immunology USA Title Grant Type Focus Area Country Application Due Date COVID-19 Vaccine Patient Education: Addressing Vaccine HesitancyRelease Date:Education Vaccines All Junior Investigator Transthyretin Amyloid Cardiomyopathy (ATTR-CM) ResearchRelease Date:Research Rare Disease All Junior Investigator Transthyretin Amyloid Polyneuropathy (ATTR-PN) ResearchRelease Date:Research Rare Disease All Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in CanadaRelease Date:Research Rare Disease Canada Quality Improvement Grants to Support the Development of Cardiac Amyloid CentersRelease Date:Quality Improvement Rare Disease Canada 2021 Growth Hormone Research (United States)Release Date:Research Rare Disease USA AcromegalyRelease Date:Research Rare Disease USA Pediatric Endocrinology FellowshipRelease Date:Fellowship Rare Disease USA Providing Access to Learning Resources for Tobacco Dependence TreatmentEducation Internal Medicine Bahrain, Egypt, Kuwait, Oman, Qatar, Saudi Arabia, South Africa, United Arab Emirates 2021 Global ANGPTL3 ASPIRERelease Date:Research Internal Medicine All Inflammatory Bowel Disease (Europe, Israel, Turkey, Russia, Canada, Australia, New Zealand and Japan)Release Date:Fellowship Inflammation & Immunology All Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA